Truist Securities Downgrades Exelixis to Hold, Raises Price Target to $54

Benzinga Newsdesk www.benzinga.com Negative 59.7%

Neg 59.7% Neu 0% Pos 0%

Truist Securities analyst Gregory Renza downgrades Exelixis (NASDAQ:EXEL) from Buy to Hold and raises the price target from $51 to $54.